1. Home
  2. OCGN vs ATNI Comparison

OCGN vs ATNI Comparison

Compare OCGN & ATNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCGN
  • ATNI
  • Stock Information
  • Founded
  • OCGN 2013
  • ATNI 1987
  • Country
  • OCGN United States
  • ATNI United States
  • Employees
  • OCGN N/A
  • ATNI N/A
  • Industry
  • OCGN Biotechnology: Biological Products (No Diagnostic Substances)
  • ATNI Telecommunications Equipment
  • Sector
  • OCGN Health Care
  • ATNI Telecommunications
  • Exchange
  • OCGN Nasdaq
  • ATNI Nasdaq
  • Market Cap
  • OCGN 246.8M
  • ATNI 251.3M
  • IPO Year
  • OCGN N/A
  • ATNI 1991
  • Fundamental
  • Price
  • OCGN $0.89
  • ATNI $16.44
  • Analyst Decision
  • OCGN Strong Buy
  • ATNI Strong Buy
  • Analyst Count
  • OCGN 3
  • ATNI 2
  • Target Price
  • OCGN $5.67
  • ATNI $31.00
  • AVG Volume (30 Days)
  • OCGN 6.1M
  • ATNI 100.9K
  • Earning Date
  • OCGN 11-08-2024
  • ATNI 02-19-2025
  • Dividend Yield
  • OCGN N/A
  • ATNI 5.84%
  • EPS Growth
  • OCGN N/A
  • ATNI N/A
  • EPS
  • OCGN N/A
  • ATNI N/A
  • Revenue
  • OCGN $4,700,000.00
  • ATNI $747,493,000.00
  • Revenue This Year
  • OCGN N/A
  • ATNI N/A
  • Revenue Next Year
  • OCGN N/A
  • ATNI $1.20
  • P/E Ratio
  • OCGN N/A
  • ATNI N/A
  • Revenue Growth
  • OCGN N/A
  • ATNI N/A
  • 52 Week Low
  • OCGN $0.49
  • ATNI $16.04
  • 52 Week High
  • OCGN $2.11
  • ATNI $38.96
  • Technical
  • Relative Strength Index (RSI)
  • OCGN 54.92
  • ATNI 26.87
  • Support Level
  • OCGN $0.79
  • ATNI $16.05
  • Resistance Level
  • OCGN $0.88
  • ATNI $17.17
  • Average True Range (ATR)
  • OCGN 0.08
  • ATNI 0.73
  • MACD
  • OCGN 0.01
  • ATNI 0.17
  • Stochastic Oscillator
  • OCGN 65.97
  • ATNI 19.80

About OCGN Ocugen Inc.

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

About ATNI ATN International Inc.

ATN International Inc is a telecommunications and utilities company. The company provides digital infrastructure and communications services with a focus on rural and remote markets in the United States, and internationally, including Bermuda and the Caribbean region. Its operating segments comprise US Telecom and International Telecom. The company earns revenue from its telecommunication services.

Share on Social Networks: